ArticleIn vivo (Athens, Greece)

Safety and Effectiveness of Ixazomib Dose-escalating Strategy in Ixazomib-Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma.

Yasukata Ohashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.